Save up to
98%
vs. average UK or US prices
Medically reviewed by
Fahad MawloodMedical Disclaimer: Data verified by Bookimed as of May 2026, based on patient requests and official quotes from 73 clinics worldwide. Median costs are based on real invoices (2024–2026) and updated monthly. Actual prices may vary.
Prof. Dr. Cüneyt Türkmen has performed 1,100+ Lutetium-177 therapy procedures over 28 years of experience specializing in nuclear medicine. Treatment at Memorial Şişli typically costs around $6,500 per course – covering the therapy, 1 day hospitalization, and pre-treatment consultation. The JCI-accredited hospital uses PSMA PET-CT for precise therapy selection. Prof. Türkmen is an European Association of Nuclear Medicine member with 86+ scientific publications.
This package follows American standards through its affiliation with Johns Hopkins Medicine at the JCI-accredited Anadolu Medical Center. Dr. Kezban Berberoglu leads the evaluation and administration in a structured 4-day cycle: diagnostics on day two, Lu-177 PSMA therapy on day three, and a post-treatment scan on day four. The total cost is approximately $10,000, covering the therapy and associated medical supervision. Patients receive comprehensive support with free airport transfers, interpreters, and a medical second opinion to streamline their international care journey.
This LUTETHIUM THERAPY package targets PSMA-positive cancer with a dose capacity up to 200 mCi of Lutetium-177. Associate Professor Tamer Aksoy, a nuclear medicine specialist with 25+ years of experience and clinical research at the Netherlands Cancer Institute, delivers the treatment. It involves a planned protocol of 6–8 sessions at Hisar Hospital Intercontinental. Costs are approximately $8,800, which includes each therapy session, VIP transfers, a personal assistant, and translation services. The JCI-accredited Nuclear Medicine department provides PET/CT imaging validation for treatment planning.
Germany offers immediate access to specific molecular diagnostics and therapies like Actinium-225 often before they reach other markets. Hospitals utilize genetic profiling to match treatments to tumor biology. This precision helps preserve healthy tissue and reduces common side effects like hair loss or severe nausea.
Bookimed Expert Insight: German oncology centers often provide compassionate use programs for new medications. This allows patients to access specific targeted drugs that may still be pending final regulatory approval elsewhere. Researching centers like Nordwest, which houses five distinct research institutes, can reveal dedicated programs for rare mutations.
What patients say: Patients note the relief of experiencing fewer side effects compared to traditional chemotherapy. They describe German care as efficient but remark on the heavy paperwork required. Many find the clinical approach highly personalized and appreciate the rapid access to new treatment options.
Dr. Joan Carles Galceran, with around 30 years of oncology experience and 120+ scientific publications, leads this targeted therapy per Memorial Sloan Kettering Cancer Center guidelines. The single-dose package costs approximately $14,410, covering a complete blood count with cancer markers and proteinogram. At the JCI-accredited Centro Médico Teknon, which has a 4.7/5 patient rating, he specializes in sarcomas, melanomas, and genitourinary cancers. Online consultations are available for efficient planning.
Austria offers precision medicine through genomic profiling and tumor boards. Specialists match cancer genes to specific drugs. This spares healthy tissue and reduces side effects. Most clinics have no waiting times. This allows immediate treatment for 150,000 international patients annually.
Bookimed Expert Insight: Vienna clinics offer a unique connection to university research. Many specialists, such as Dr. Wolfgang Köstler, lead clinical trials. This ensures patients receive the latest drug resistance protocols directly from the researchers. Targeted therapy starts from $12,000 to $28,000.
What patients say: Patients in Austria notice high efficiency and very clean, modern facilities. They value the quick scheduling for personalized treatments. Many emphasize checking insurance or EU paperwork early to avoid delays.
Israel offers immediate access to genomic profiling and biomarker testing for cancer treatment. Patients receive medications like Lutetium-177 or Kadcyla sooner due to simplified regulatory paths compared to the US. Top centers use these high-precision tools to match drug therapies to specific tumor mutations.
Bookimed Expert Insight: Tel Aviv has the highest density of JCI-accredited centers for targeted therapy. Specialists here, such as Dr. Ari Raphael, focus on clinical trial enrollment. This provides patients with access to new drug protocols before they reach global markets. Targeted therapy in Israel costs from $9,500 to $19,500.
What patients say: Patients note that Israel offers faster access to new drugs than most Western countries. They appreciate how oncologists explain the treatment rationale and manage drug side effects proactively. The care feels personalized because genomic testing is part of the initial diagnostic process.
Prof. Dr. David Sarid, an Oxford-trained uro-oncology specialist with 30+ publications, leads the targeted therapy program at Sourasky Medical Center. The consultation with therapy planning may cost around $950, typically including genomic testing and multidisciplinary team review. The center offers Lutetium-177 PSMA therapy – one of few worldwide combining diagnostic PET/CT with targeted radionuclide treatment. JCI-accredited with a 90% oncology success rate, the hospital provides access to experimental therapies via clinical trials.
Transparent methodology - so you can trust our recommendations.
Whether you're looking for the cheapest place to get targeted therapy or the highest-rated specialists abroad, Bookimed's ranking accounts for everything that matters. It uses a smart algorithm that continuously analyzes real-world data from verified verified clinics worldwide, including:
1,182 patient requests
We analyze thousands of real cases to identify destinations with the highest patient demand and best outcomes for targeted therapy.
17 verified patient reviews
Real feedback on hospital facilities, staff communication, recovery experience, and long-term results.
Accreditation standards
International accreditations such as JCI and ISO 9001, or equivalent national certifications, verified annually.
Board-certified specialists
Evaluated by credentials, volume of successful cases for targeted therapy, and specialized training.
Transparent price data
Aggregated directly from clinics and cross-checked against other ranking criteria - so the cheapest countries for targeted therapy on our list are also among the safest.
Medical excellence & innovation
We prioritize countries using the latest techniques and equipment for targeted therapy, with proven track records in international patient care.
Choosing a country for Targeted therapy abroad shouldn't come down to guesswork. Having helped over 900,000 patients, we know which destinations combine the best specialists, safest hospitals, and affordable prices. We're here to help you find the right one.
Targeted therapy (targeted therapy, molecular targeted therapy, molecular targeted therapy) is a medical treatment of cancer using drugs that act specifically on cancer cells and do not harm healthy tissues.
Doctors may prescribe it as the main method of treatment or in combination with other procedures - surgery, radiation and chemotherapy.
The principle of operation of a targeted drug depends on its type. The American Cancer Society identifies the following goals for targeted therapy:
Depending on the active substance that is part of the drug, the Canadian Cancer Society distinguishes the following types of molecular targeted therapy:
When entering the body, monoclonal antibodies find cancer cells, attach to the shell and trigger a self-destruction mechanism in them.
Monoclonal antibodies also increase the effectiveness of chemotherapy and radiation therapy - they help chemotherapy drugs and radiation to penetrate into the cancer cell and destroy it.
The names of all drugs containing monoclonal antibodies end in “mab” (for example, Pembrolizumab, Trastuzumab, Rituximab, etc.).
Interesting to know:
Monoclonal antibodies are also used in immunotherapy, because they activate the immune system and it begins to destroy the tumor on its own.
Tyrosine kinase inhibitors block the signaling of a cancer cell that causes it to grow.
The name of such drugs ends with “nib” (Imatinib, Gefitinib, etc.)
Such drugs activate signals in cancer cells that cause them to die.
Apoptosis-inducing drugs include Oblimersen, Bortezomib, Olaparib.
They prevent the development of new blood vessels that feed the tumor.
Angiogenesis inhibitors include Sunitinib, Bevacizumab, and Thalidomide.
The substance blocks a protein that is responsible for the growth and division of cancer cells.
Medications based on mTOR inhibitors - Everolimus, Temsirolimus.
Hormone therapy is a subspecies of targeted therapy. It prevents hormones (estrogen, testosterone, and progesterone) from binding to receptors that help cancer cells grow. Due to this, the tumor dies.
To select a targeted therapy drug and determine the duration of treatment, the doctor prescribes an immunohistochemical study - an analysis of tumor tissue obtained by biopsy. It allows you to determine the type of cancer cells and identify genetic mutations and proteins that are targets for targeted drugs.
If the patient has already taken the material, it is necessary to bring blocks and glasses with you to the clinic. Doctors will review them and the procedure will not have to be repeated.
A unique test to select the most effective drug
The FoundationOne tumor test is available at the Ichilov and Assuta Clinic (Israel) and the Anadolu Medical Center (Turkey). It allows you to determine which target drug the tumor is most sensitive to. This test requires special laboratory equipment and doctor's qualifications, therefore it is available only in some clinics around the world.
Targeted therapy is inpatient or outpatient, depending on the general condition of the patient and the need for additional treatment. At the same time, it is not necessary to stay in the country in which you were selected and prescribed the drug. You can buy medicine, return home and take it according to the prescribed regimen in your place of residence.
The duration of 1 course of targeted therapy is individual. On average, it is 2 weeks. The doctor determines the number of courses individually for each patient. This is influenced by the diagnosis, general health, disease and body response to drugs.
Because targeted drugs target cancer cells, this treatment is easier than chemotherapy. However, there is a risk of certain complications. The American Cancer Society lists them as:
The price of targeted therapy depends on:
In our catalog, in the cards of clinics, the price is indicated for 1 course of treatment with targeted drugs. The required number of courses is determined by the attending physician based on the diagnostic results. Therefore, you can find out the final cost of targeted therapy after the doctor gets acquainted with the diagnosis and the results of the examination.
Leave a request on our website, and a Bookimed coordinating doctor will contact you at a convenient time for you. He will talk about the features of the technique, orient on the cost. Together with the coordinating doctor, you will select the best medical center for your case.
Our care department will help you arrange your travel for treatment and will stay in touch with you from the moment you contact us and even after you return home.
You do not pay for Bookimed services.
Targeted therapy is most successfully used in lung cancer, breast cancer, and ovarian cancer most commonly. It is also used in brain tumors, liver cancer, and kidney cancer.
